Skip to content

Depression: all studies

Page 893 of 1,034: studies 8,921 to 8,930 of 10,336, newest first. Back to the depression overview

Research

Living with chronic pain: Evaluating patient experiences with a medical group visit focused on mindfulness and non-pharmacological strategies.

Complementary Therapies in Medicine December 2017 Anna Sophia Lestoquoy, Lance D Laird, Suzanne H. Mitchell et al.

Little is known about the acceptance of non-pharmacological group strategies delivered to low income racially diverse patients with chronic pain and depression. This paper examines how the Integrative Medical Group Visit (IMGV) addresses many of the deficits identified with usual care. Six IMGVs cohorts were held at a safety net hospital and two federally funded community health centres. Data...

DOI: 10.1016/j.ctim.2017.09.002 (opens in new tab) Full text (opens in new tab) Mindfulness Chronic pain Group medical visits Integrative medicine +1

[Mindfulness-based interventions in obsessive-compulsive disorder: Mechanisms of action and presentation of a pilot study].

L'Encephale December 2017 M Gasnier, A Pelissolo, Guido Bondolfi et al.

Obsessive-compulsive disorder (OCD) is a frequent and severe disease, potentially inducing a major impairment for the patient and burden for their family. Recent research in psychiatry and neuroscience have led to better comprehension of the disease's mechanisms and helped to improve its treatment. However, a large proportion of patients have refractory symptoms, including for traditional...

DOI: 10.1016/j.encep.2016.10.004 (opens in new tab) Full text (opens in new tab) Mindfulness Obsessive-compulsive disorder Pilot study Trouble obsessionnel compulsif +1

Does mindfulness meditation improve chronic pain? A systematic review

Current Opinion in Obstetrics & Gynecology December 1, 2017 Elizabeth F. Ball, Emira Nur Shafina Muhammad Sharizan, Genny Franklin et al.

Purpose of review Psychological factors are associated with chronic pain. Mindfulness meditation may ameliorate symptoms. The objective was to evaluate the effects of mindfulness meditation in chronic pain. Recent findings A systematic search of four databases identified 534 citations; 13 Randomised controlled trials satisfied the inclusion criteria. Mindfulness meditation significantly reduced...

Mindfulness-Based Interventions During Pregnancy: a Systematic Review and Meta-analysis

Mindfulness December 1, 2017 Anjulie Dhillon, Elizabeth Sparkes, Rui V. Duarte

This systematic review aims to assess the effect of mindfulness-based interventions carried out during pregnancy exploring mindfulness and mental health outcomes. A systematic review was conducted to appraise the current literature on the subject area. Inclusion and exclusion criteria were agreed and after reviewing titles, abstracts and full papers, 14 articles met the inclusion criteria and...

Selected relaxation techniques and possibilities of their use in the context of stress-related psychophysical disorders and diseases

Neuropsychiatria i Neuropsychologia November 30, 2017 K. Rygiel

Choroby zwizane ze stresem stanowi rosnce obcienie dla systemu opieki zdrowotnej i dla spoeczestwa. Aby zaspokoi biece potrzeby w tym zakresie poszukiwane s innowacyjne, bezpieczne i skuteczne metody, do ktrych nale midzy innymi techniki relaksacyjne. W szczeglnoci medytacja transcedentalna (transcendental meditation -TM) i redukcja stresu oparta na uwanoci (mindfulness-based stress reduction...

The Effectiveness of a Body-Affective Mindfulness Intervention for Multiple Sclerosis Patients with Depressive Symptoms: A Randomized Controlled Clinical Trial

Frontiers in Psychology November 30, 2017 Sara Carletto, Valentina Tesio, Martina Borghi et al. 49 citations

Purpose Mindfulness interventions have been shown to treat depressive symptoms and improve quality of life in patients with several chronic diseases, including multiple sclerosis, but to date most evaluation of the effectiveness of mindfulness interventions in multiple sclerosis have used patients receiving standard care as the control group. Hence we decided to evaluate the effectiveness of a...

Subcortical Local Functional Hyperconnectivity in Cannabis Dependence

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging November 23, 2017 Peter Manza, Dardo G. Tomasi, Nora D. Volkow 61 citations

BACKGROUND: Cannabis abuse (CA) has been associated with psychopathology, including negative emotionality and higher risk of psychosis, particularly with early age of initiation. However, the mechanisms underlying this association are poorly understood. Because aberrant dopamine signaling is implicated in cannabis-associated psychopathology, we hypothesized that regular CA would be associated...

Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing

The International Journal of Neuropsychopharmacology November 22, 2017 André Schmidt, Felix Müller, Patrick C. Dolder et al. 25 citations

Background: Stimulants such as methylphenidate and modafinil are frequently used as cognitive enhancers in healthy people, whereas 3,4-methylenedioxymethamphetamine (ecstasy) is proposed to enhance mood and empathy in healthy subjects. However, comparative data on the effects of methylphenidate and modafinil on negative emotions in healthy subjects have been partially missing. The aim of this...

DOI: 10.1093/ijnp/pyx112 (opens in new tab) Full text (opens in new tab) MDMA Modafinil Methylphenidate Dextroamphetamine +1

TrkB dependent adult hippocampal progenitor differentiation mediates sustained ketamine antidepressant response

Nature Communications November 21, 2017 Zhenzhong Ma, Tong Zang, Shari G. Birnbaum et al.

Adult neurogenesis persists in the rodent dentate gyrus and is stimulated by chronic treatment with conventional antidepressants through BDNF/TrkB signaling. Ketamine in low doses produces both rapid and sustained antidepressant effects in patients. Previous studies have shed light on post-transcriptional synaptic NMDAR mediated mechanisms underlying the acute effect, but how ketamine acts at...

Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit

Molecular Psychiatry November 21, 2017 Ning Yao, Olga Skiteva, Xue-Qin Zhang et al. 123 citations

Low doses of ketamine trigger rapid and lasting antidepressant effects after one injection in treatment-resistant patients with major depressive disorder. Modulation of AMPA receptors (AMPARs) in the hippocampus and prefrontal cortex is suggested to mediate the antidepressant action of ketamine and of one of its metabolites (2R,6R)-hydroxynorketamine ((2R,6R)-HNK). We have examined whether...